[
  {
    "ts": null,
    "headline": "Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK",
    "summary": "NEW YORK, April 14, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Merck & Co., Inc. . Such investors are advised to contact Danielle Peyton at...",
    "url": "https://finnhub.io/api/news?id=d466604710d9c08c1147ce0a75b2b6621167bde1b735e6881fdb9ee64f3c217a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744647316,
      "headline": "Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK",
      "id": 133909403,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "NEW YORK, April 14, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Merck & Co., Inc. . Such investors are advised to contact Danielle Peyton at...",
      "url": "https://finnhub.io/api/news?id=d466604710d9c08c1147ce0a75b2b6621167bde1b735e6881fdb9ee64f3c217a"
    }
  },
  {
    "ts": null,
    "headline": "ABBV vs. MRK: Which Drug Giant is a Better Buy Now?",
    "summary": "Both ABBV and MRK are leading pharmaceutical companies with strong portfolios in oncology and immunology.",
    "url": "https://finnhub.io/api/news?id=4bdba72a3bcf30342f973c0f8a956c0bf40c175fae9abc33862915ac771d5d92",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744641420,
      "headline": "ABBV vs. MRK: Which Drug Giant is a Better Buy Now?",
      "id": 133908235,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Both ABBV and MRK are leading pharmaceutical companies with strong portfolios in oncology and immunology.",
      "url": "https://finnhub.io/api/news?id=4bdba72a3bcf30342f973c0f8a956c0bf40c175fae9abc33862915ac771d5d92"
    }
  },
  {
    "ts": null,
    "headline": "Is Merck & Co. (NYSE:MRK) a Cheap NYSE Stock to Invest in According to Hedge Funds?",
    "summary": "We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going to take a look at where Merck & Co. (NYSE:MRK) stands against other cheap NYSE stocks. On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends […]",
    "url": "https://finnhub.io/api/news?id=e152d265d017e8630ed6bd0f53538892cb859acadf0fa70f05f7860dc9be1d3a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744640950,
      "headline": "Is Merck & Co. (NYSE:MRK) a Cheap NYSE Stock to Invest in According to Hedge Funds?",
      "id": 133908277,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going to take a look at where Merck & Co. (NYSE:MRK) stands against other cheap NYSE stocks. On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends […]",
      "url": "https://finnhub.io/api/news?id=e152d265d017e8630ed6bd0f53538892cb859acadf0fa70f05f7860dc9be1d3a"
    }
  },
  {
    "ts": null,
    "headline": "MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm",
    "summary": "The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Merck & Co., Inc. for violations of §§10 and 20 of the Securities Exchange...",
    "url": "https://finnhub.io/api/news?id=8e4bafa1f9c10181bb8b2b5144b821c562a451db549409ed900fc08366c82ed7",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744633383,
      "headline": "MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm",
      "id": 133907642,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Merck & Co., Inc. for violations of §§10 and 20 of the Securities Exchange...",
      "url": "https://finnhub.io/api/news?id=8e4bafa1f9c10181bb8b2b5144b821c562a451db549409ed900fc08366c82ed7"
    }
  },
  {
    "ts": null,
    "headline": "FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.",
    "summary": "Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Merck To Contact Him Directly To Discuss Their OptionsIf you suffered...",
    "url": "https://finnhub.io/api/news?id=df50184bda0d7f1142b28d3fcfeb8199f3e0b959015e28cb0c3feaf62fe55eb8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744625944,
      "headline": "FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.",
      "id": 133907014,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Merck To Contact Him Directly To Discuss Their OptionsIf you suffered...",
      "url": "https://finnhub.io/api/news?id=df50184bda0d7f1142b28d3fcfeb8199f3e0b959015e28cb0c3feaf62fe55eb8"
    }
  },
  {
    "ts": null,
    "headline": "Summit Therapeutics: Multibillion Dollar NSCLC Potential Faces Growing Competition",
    "summary": "Summit Therapeutics: Multibillion Dollar NSCLC Potential Faces Growing Competition",
    "url": "https://finnhub.io/api/news?id=3f7294d4d1517918e9a4c887fc4b98f5c253e52d586c4951d103dba25da6944a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744621700,
      "headline": "Summit Therapeutics: Multibillion Dollar NSCLC Potential Faces Growing Competition",
      "id": 133906687,
      "image": "",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=3f7294d4d1517918e9a4c887fc4b98f5c253e52d586c4951d103dba25da6944a"
    }
  },
  {
    "ts": null,
    "headline": "Vaccine Producer Wins Summary Judgment Argument Due To Implied Preemption",
    "summary": "On March 11, 2025, Judge Kenneth Bell in the Western District of North Carolina granted summary judgment in favor of Merck & Co. Inc. and Merck Sharp Dohme LLC against the bellwether plaintiffs in a...",
    "url": "https://finnhub.io/api/news?id=fc05af46fd798e390fc4d1a2ad9753a7690cec8a3ce2044f5fe7139b3f358fc3",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744596733,
      "headline": "Vaccine Producer Wins Summary Judgment Argument Due To Implied Preemption",
      "id": 133904128,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "On March 11, 2025, Judge Kenneth Bell in the Western District of North Carolina granted summary judgment in favor of Merck & Co. Inc. and Merck Sharp Dohme LLC against the bellwether plaintiffs in a...",
      "url": "https://finnhub.io/api/news?id=fc05af46fd798e390fc4d1a2ad9753a7690cec8a3ce2044f5fe7139b3f358fc3"
    }
  }
]